title: Pegloticase for treatment of tophaceous polyarticular gout.
abstract: This is a case report of a patient with treatment resistant gout who was prescribed pegloticase and developed a severe reaction. A 30-year-old Hawaiian-Filipino man presented with a nine-year history of gout that progressed from episodic monoarticular arthritis, treated with aspiration and corticosteroid injections, to more aggressive disease with more frequent attacks requiring escalation of therapy. He was treated with systemic corticosteroids, colchicine and nonsteroidal anti-inflammatory drugs, but then required allopurinol. Despite aggressive therapy, the patient continued to have hyperuricemia and tophi developed even after treatment with febuxostat and probenicid. The patient became wheel chair bound due to his pain and, at that point, the decision was made to initiate treatment with pegloticase. The patient initially experienced significant improvement with treatment; however, he soon began to have elevation in his serum uric acid levels and developed a severe reaction during treatment.
authors.affiliation: Tripler Army Medical Center, Honolulu, HI 96859, USA. Rebecca.Seifried@us.army.mil
authors.forename: Rebecca M
authors.initials: RM
authors.lastname: Seifried
authors.forename: Jefferson
authors.initials: J
authors.lastname: Roberts
mesh_terms: D000328:Adult; D015210:Arthritis, Gouty / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000069465:Febuxostat; D006074:Gout Suppressants / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use; D014503:Urate Oxidase / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood
chemical_list: D006074:Gout Suppressants; D013844:Thiazoles; D000069465:Febuxostat; D014527:Uric Acid; D011092:Polyethylene Glycols; D014503:Urate Oxidase; C031545:Pegloticase
keywords: infusion reaction; pegloticase; tophi; treatment resistant gout
references.citation: Arthritis Rheum. 2007 Oct 15;57(7):1324-8
references.pmid: 17907217
references.citation: J Rheumatol. 2004 Aug;31(8):1582-7
references.pmid: 15290739
references.citation: Rheumatology (Oxford). 2009 May;48 Suppl 2:ii2-ii8
references.pmid: 19447779
references.citation: J Rheumatol. 2009 Jun;36(6):1273-82
references.pmid: 19286847
references.citation: Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):69-75
references.pmid: 19075968
references.citation: Postgrad Med. 2011 Nov;123(6 Suppl 1):3-36
references.pmid: 22156509
references.citation: Mayo Clin Proc. 2006 Jul;81(7):925-34
references.pmid: 16835972
references.citation: Cleve Clin J Med. 2008 Jul;75 Suppl 5:S9-12
references.pmid: 18819329